TY - GEN AU - Laniece Delaunay, Charlotte AU - Martínez-Baz, Iván AU - Sève, Noémie AU - Domegan, Lisa AU - Mazagatos, Clara AU - Buda, Silke AU - Meijer, Adam AU - Kislaya, Irina AU - Pascu, Catalina AU - Carnahan, AnnaSara AU - Oroszi, Beatrix AU - Ilić, Maja AU - Maurel, Marine AU - Melo, Aryse AU - Sandonis-Martin, Virginia AU - Trobajo-Sanmartín, Camino AU - Enouf, Vincent AU - McKenna, Adele AU - Pérez-Gimeno, Gloria AU - Goerlitz, Luise AU - de Lange, Marit AU - Rodrigues, Ana Paula AU - Lazar, Mihaela AU - Latorre-Margalef, Neus AU - Túri, Gergő AU - Castilla, Jesús AU - Falchi, Alessandra AU - Bennett, Charlene AU - Gallardo, Virtudes AU - Dürrwald, Ralf AU - Eggink, Dirk AU - Guiomar, Raquel AU - Popescu, Rodica AU - Riess, Maximilian AU - Horváth, Judit Krisztina AU - Casado, Itziar AU - García, Mª Del Carmen AU - Hooiveld, Mariëtte AU - Machado, Ausenda AU - Bacci, Sabrina AU - Kaczmarek, Marlena AU - Kissling, Esther AU - European Primary Care Vaccine Effectiveness Group PY - 2024 DO - 10.2807/1560-7917.ES.2024.29.13.2300403 SN - 1025-496X UR - https://hdl.handle.net/20.500.12105/26420 AB - Background: Scarce European data in early 2021 suggested lower vaccine effectiveness (VE) against SARS-CoV-2 Omicron lineages than previous variants. Aim: We aimed to estimate primary series (PS) and first booster VE against symptomatic BA.1/BA.2... LA - eng PB - European Centre for Disease Prevention and Control (ECDC) KW - BA.1 KW - BA.2 KW - COVID-19 KW - SARS-CoV-2 KW - Test-negative design KW - Vaccine effectiveness KW - Symptomatic infection KW - Adolescent KW - Aged KW - BNT162 Vaccine KW - COVID-19 Vaccines KW - COVID-19 KW - Europe KW - Humans KW - Influenza, Human KW - Primary Health Care KW - SARS-CoV-2 KW - Vaccine Efficacy TI - COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022 TY - research article ER -